102 related articles for article (PubMed ID: 19420046)
1. Natriuretic peptides in elderly people with acute myocardial infarction.
Ribeiro AL
BMJ; 2009 May; 338():b787. PubMed ID: 19420046
[No Abstract] [Full Text] [Related]
2. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction.
Lorgis L; Cottin Y; Danchin N; Mock L; Sicard P; Buffet P; L'huillier I; Richard C; Beer JC; Touzery C; Gambert P; Zeller M;
Heart; 2011 Apr; 97(7):551-6. PubMed ID: 21343169
[TBL] [Abstract][Full Text] [Related]
3. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in clinical practice.
Alpert JS
Am J Med; 2011 Aug; 124(8):677-8. PubMed ID: 21683327
[No Abstract] [Full Text] [Related]
5. The influence of renal function on the prognostic value of NT-pro brain natriuretic peptide in ST-elevation myocardial infarction.
Lazzeri C; Valente S; Chiostri M; Attanà P; Picariello C; Gensini GF
Int J Cardiol; 2012 May; 156(3):333-5. PubMed ID: 22386698
[No Abstract] [Full Text] [Related]
6. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
[TBL] [Abstract][Full Text] [Related]
7. Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI.
Bruder O; Jensen C; Jochims M; Farazandeh M; Barkhausen J; Schlosser T; Sabin GV; Hunold P
Int J Cardiol; 2010 Sep; 144(1):53-8. PubMed ID: 19410308
[TBL] [Abstract][Full Text] [Related]
8. Advancing perioperative prediction of cardiac risk after vascular surgery: does postoperative N-terminal pro-brain natriuretic peptide do the trick?
Augoustides J; Fleisher LA
Anesthesiology; 2007 Jun; 106(6):1080-2. PubMed ID: 17525578
[No Abstract] [Full Text] [Related]
9. Natriuretic peptides for risk stratification of patients with acute coronary syndromes.
Galvani M; Ferrini D; Ottani F
Eur J Heart Fail; 2004 Mar; 6(3):327-33. PubMed ID: 14987584
[TBL] [Abstract][Full Text] [Related]
10. BNP: not just for heart failure.
Nicholls MG; Frampton CM; Yandle TG
Heart; 2008 Jan; 94(1):6-7. PubMed ID: 18083945
[No Abstract] [Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide and tombstoning ST-segment elevation in patients with anterior wall acute myocardial infarction.
Tomcsányi J; Marosi A; Bózsik B; Somlói M; Zsoldos A; Vecsey T; Arabadzisz H; Nagy E
Am J Cardiol; 2005 Nov; 96(9):1197-9. PubMed ID: 16253581
[TBL] [Abstract][Full Text] [Related]
12. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
13. Plasma N-terminal Pro-Brain Natriuretic Peptide (Nt-proBNP) level and prognosis after myocardial infarction in diabetes.
Vergès B; Zeller M; Beer JC; Cottin Y;
Diabetes Metab; 2008 Feb; 34 Suppl 1():S10-5. PubMed ID: 18358421
[TBL] [Abstract][Full Text] [Related]
14. Plasma urocortin in acute myocardial infarction patients.
Phrommintikul A; Sivasinprasasn S; Lailerd N; Chattipakorn S; Kuanprasert S; Chattipakorn N
Eur J Clin Invest; 2010 Oct; 40(10):874-82. PubMed ID: 20636379
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunction, hemodialysis, and the NT-proBNP/BNP ratio.
Jacobs LH; Mingels AM; Wodzig WK; van Dieijen-Visser MP; Kooman JP
Am J Clin Pathol; 2010 Sep; 134(3):516-7; author reply 517. PubMed ID: 20716809
[No Abstract] [Full Text] [Related]
16. Developing the utility of blood biomarker associations beyond population sample linkage to events in cardiovascular patients.
Macfadyen RJ; Ng Kam Chuen MJ
Eur Heart J; 2008 Apr; 29(7):837-9. PubMed ID: 18334472
[No Abstract] [Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
18. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.
Sajadieh A; Nielsen OW; Rasmussen V; Ole Hein H; Hansen JF
Pacing Clin Electrophysiol; 2006 Nov; 29(11):1188-94. PubMed ID: 17100670
[TBL] [Abstract][Full Text] [Related]
19. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes.
de Lemos JA; Morrow DA
Am Heart J; 2007 Apr; 153(4):450-3. PubMed ID: 17383278
[No Abstract] [Full Text] [Related]
20. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
